{
    "code": "06021375",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06021375",
    "time": "2020-02-25 20:08:39",
    "許可證字號": "衛署醫器輸字第021375號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD4354",
    "有效日期": "109\/08\/04",
    "發證日期": "99\/08\/04",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00602137507",
    "中文品名": "宜立亞高感度PR3抗體檢測試劑",
    "英文品名": "EliA PR3s well",
    "效能": "EliA PR3s 抗體檢測的目的是進行人類血清及血漿中抗蛋白&#37238;3(PR3)之IgG抗體的體外定量分析。",
    "醫器規格": "#14-5536:4 carriers (12 wells each); sufficient for 48 determinations.",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器次類別一": "C5660多發性自體抗體免疫試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "620110P095  台灣法迪亞股份有限公司",
    "申請商地址": "台北市內湖區洲子街85號6樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "MSE0039000  PHADIA AB",
            "製造廠廠址": "RAPSGATAN 7,P.O. BOX 6460-SE751 37, UPPSALA, SWEDEN",
            "製造廠公司地址": "",
            "製造廠國別": "SWEDEN",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060213750001-104-07-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06021375&Seq=002&Type=9"
        },
        {
            "title": "06021375001___20121206.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06021375&Seq=001&Type=9"
        },
        {
            "title": "06021375001___20121206.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06021375&Seq=001&Type=8"
        }
    ]
}